- CEO
- I-Lee Hsu
- Full Time Employees
- 270
- Sector
- Consumer non-durables
- Industry
- Tobacco
- Address
- Guoco Tower Kuala Lumpur WP Malaysia 50490
- IPO Date
- Oct 27, 1961
- Business
- British American Tobacco (Malaysia) Berhad British American Tobacco (Malaysia) Berhad engages primarily in the importation, marketing, and sale of cigarettes and related tobacco products in Malaysia. The company offers a portfolio of premium and value-for-money cigarette brands including Dunhill, Benson & Hedges, Peter Stuyvesant, Rothmans, KYO, and Luckies; it also provides nicotine vapour products such as Vuse, alongside capabilities in tobacco heating products like glo, modern oral products including tobacco-free nicotine pouches, and traditional oral products such as moist snuff and snus. British American Tobacco (Malaysia) Berhad operates through subsidiaries like Commercial Marketers and Distributors Sdn. Bhd. and Tobacco Importers and Manufacturers Sdn. Berhad, maintaining approximately 50.5% domestic market share and 13 branch offices across Malaysia.
Formed on 3 November 1999 through the merger of Rothmans of Pall Mall (Malaysia) Berhad and Malaysian Tobacco Company Berhad, the company traces its roots in Malaysia to 1912 and is headquartered at Level 19, Guoco Tower, Damansara City, No. 6 Jalan Damanlela, Bukit Damansara, Kuala Lumpur, 50490, Malaysia. It employs 283 people and is listed on the Main Market of Bursa Malaysia Securities Berhad under ticker 4162.KL, with British American Tobacco Holdings (Malaysia) B.V., a subsidiary of British American Tobacco p.l.c., as its major shareholder holding 50%.
In recent developments, British American Tobacco (Malaysia) Berhad exited its vapor business in Malaysia to refocus on core combustible segments amid regulatory pressures and strategic alignment with its parent company's global shift toward reduced-risk products, though execution faces market challenges. The company expressed optimism for stable FY2024 performance at its 63rd Annual General Meeting in May 2024, emphasizing growth in premium and aspirational premium brands while navigating the Control of Smoking Products for Public Health Act 2024; it also reported Q3 2024 EPS of RM0.24 and projects 10% annual revenue growth over the next three years. These moves support its broader strategy to deliver combustible value growth and build a portfolio of reduced-risk products in a challenging regulatory environment.